Obstetrics/Gynecology
RSSArticles
-
Treatment of Tuberculosis and Latent Tuberculosis Infection
The treatment of pulmonary tuberculosis is divided into an initial phase of four drugs for two months.
-
Pharmacology Update Medroxyprogesterone Acetate Injection (depo-subQ provera 104)
By William T. Elliott, MD, FACP, and James Chan, PhD, PharmD Dr. Elliott is Chair, Formulary Committee, Northern California Kaiser Permanente; Associate Clinical Professor of Medicine, University of California, San Francisco; Dr. Chan is Pharmacy Quality and Outcomes Manager, Kaiser Permanente, Oakland, CA. Drs. Chan and Elliott report no financial relationships to this field of study. -
Autonomic Peripheral Neuropathy
By Norm Latov, MD Professor of Neurology and Neuroscience and Director of the Peripheral Neuropathy Center at Weill Medical College at Cornell University. Dr. Latov is a consultant for Quest Diagnostics and Talecris Inc., is a stockholder of Therapath LLC, and has royalties in Athena Diagnostics. Synopsis: The availability of sensitive and reproducible measures of autonomic function has improved physicians ability to diagnose these disorders. -
Etiology of Elevated Troponin Levels Other Than in Acute Coronary Syndromes
By Harold L. Karpman, MD Clinical Professor of Medicine, UCLA School of Medicine Dr. Karpman reports no financial relationship to this field of study. -
Clinical Briefs
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment Foot Small Muscle Atrophy Before the Detection of Clinical Neuropathy Statins and the Risk of Colorectal Cancer -
Low-Dose Aspirin in the Primary Prevention of Cancer
By Barbara A. Phillips, MD, MSPH Professor of Medicine, University of Kentucky; Director, Sleep Disorders Center, Samaritan Hospital, Lexington, KY Dr. Phillips serves on the speakers bureau of Cephalon, Boehringer Ingelheim, Merck, ResMed, and GlaxoSmithKline and is a consultant for Boehringer Ingelheim, Wyeth-Ayerst, and ResMed. Synopsis: There was no overall effect of 100 mg aspirin every other day on total cancer among nearly 40,000 women randomized to aspirin or placebo and followed for an average of 10 years. -
Full July 29, 2005, Issue in PDF
-
Pharmacology Update Ibandronate Sodium Tablets (BonivaTM)
By William T. Elliott, MD, FACP, and James Chan, PharmD, PhD Dr. Elliott is Chair, Formulary Committee, Northern California Kaiser Permanente; Asst. Clinical Professor of Medicine, University of California, San Francisco; Dr. Chan is Pharmacy Quality and Outcomes Manager, Kaiser Permanente, Oakland, CA Drs. Chan and Elliott report no financial relationships to this field of study. -
Rifaximin to Control Travelers’ Diarrhea
By Malcolm Robinson, MD, FACP, FACG Emeritus Clinical Professor of Medicine, University of Oklahoma College of Medicine, Oklahoma City, OK Disclosure; Dr. Robinson serves as a consultant for TAP, Pfizer, Janssen, Eisai, J&J-Merck, and Procter & Gamble, is on the speakers bureau of Janssen, Eli Lilly, Solvay, TAP, and Aventis, and does research for Forest Labs, Wyeth-Ayerst, AstraZeneca,and Centocor. Synopsis: Rifaximin, a newly released nonabsorbed antibiotic, appears to safely and effectively prevent the onset and substantial morbidity of travelers diarrhea. -
Cardiac Resynchronization Therapy in CHF Who and When
By Harold L. Karpman, MD Clinical Professor of Medicine, UCLA School of Medicine Disclosure; Dr. Karpman reports no financial conflicts of interest in this field of study. Despite the recent explosion of pharmacologic agents available for the treatment of congestive heart failure (CHF), many patients continue to be severely symptomatic and their prognosis remains poor.